Cita APA (7a ed.)

Ghebeh, H., Al-Sayed, A., Eiada, R., Cabangon, L., Ajarim, D., Suleman, K., . . . Al-Tweigeri, T. (2021). Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Ghebeh, Hazem, Adher Al-Sayed, Riham Eiada, Leilani Cabangon, Dahish Ajarim, Kausar Suleman, Asma Tulbah, y Taher Al-Tweigeri. Weekly Paclitaxel Given Concurrently with Durvalumab Has a Favorable Safety Profile in Triple-negative Metastatic Breast Cancer. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Ghebeh, Hazem, et al. Weekly Paclitaxel Given Concurrently with Durvalumab Has a Favorable Safety Profile in Triple-negative Metastatic Breast Cancer. Nature Portfolio, 2021.